Study: Zinc, HCQ, Z-Pak Cocktail Effective Early Vs. COVID-19

An outpatient study is reporting a combination of zinc, hydroxychloroquine, and azithromycin significantly reduces hospitalization and death for COVID-19 positive patients, cutting mortality rate to a mere 0.3%.

The current COVID-19 positive case mortality rate is 5.26%, according to the study. Azithromycin is more commonly known as Z-Pak.

The key note of this study, according to CrowdProtocol doctors, is the early treatment of COVID-19 in outpatients before they require hospitalization for a severe COVID-19 case, the latter of which was used to suggest no benefit to HCQ use in hospitalized patients.

“What differentiates this study is that patients were diagnosed very early with COVID-19 in an outpatient setting and treated early on,” co-author of the study, Alexion Pharma Germany Dr. Roland Derwand said in a statement provided to Newsmax. Dr. Derwand worked the study with Dr. Martin Scholz and Dr. Vladimir Zelenko of Lenox Hill Hospital in Monroe, New York.

“Unfortunately, we seem to have forgotten that it is common medical knowledge to treat any patient with a disease as soon as possible. Dr. Zelenko treated his patients immediately with the three drugs to increase effects and didn’t wait for the disease to develop.”

A news release of the study, which has not been peer reviewed, declares hospitalization of 141 high-risk patients who were treated was 84% less likely than the untreated group. Just one patient died in the treated group vs. 13 patients that died from the untreated group.

“At this point, the media has left us with a grim view of anything related to hydroxychloroquine, but that is why studies like this are so important,” Dr. Zelenko said in a statement.

“All hydroxychloroquine does is allow the zinc to permeate the cell. Studies regarding the effectiveness of hydroxychloroquine without the use of zinc are immaterial here. The synergy of these three drugs is a rare and powerful tool that should not go unnoticed. It seems we currently have pharmaceutical capabilities at our disposal to significantly decrease hospitalizations and death by using these three drugs early and in a controlled, low-dosage manner.”

The success of early treatments of COVID-19 is crucial to curbing the hospitalizations and deaths that make COVID-19 so dangerous.

“I believe that we don’t stand powerless to coronavirus; we have the means to fight back,” Dr. Scholz said in a statement. “Together with Dr. Derwand and Dr. Zelenko, I helped create CrowdProtocol.com for this very reason — to facilitate discourse between medical professionals, COVID-19 survivors, and the general public so we can work together, and find a way to beat this.”

Read Newsmax: Study: Zinc, HCQ, Z-Pak Cocktail Effective Early Vs. COVID-19 | Newsmax.com
Urgent: Your Heart Attack Risk Determined Online – More Info